Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Hypertension on Clinical End Points: A Cohort Study
Article first published online: 9 APR 2012
© 2012 Wiley Periodicals, Inc.
The Journal of Clinical Hypertension
Volume 14, Issue 7, pages 407–414, July 2012
How to Cite
Roy, J., Shah, N. R., Wood, G. C., Townsend, R. and Hennessy, S. (2012), Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Hypertension on Clinical End Points: A Cohort Study. The Journal of Clinical Hypertension, 14: 407–414. doi: 10.1111/j.1751-7176.2012.00617.x
- Issue published online: 2 JUL 2012
- Article first published online: 9 APR 2012
- Manuscript received: December 15, 2011; Revised: January 29, 2012; Accepted: February 3, 2012
Figure S1. Plot of logit of estimated propensity scores, stratified by treatment group.
Table SI. Logistic regression model for the probability of ARB (relative to ACEI).
Table SII. Sensitivity analysis based on censoring time. Hazard ratios (95% confidence interval) for ARB vs. ACEI for study outcomes.
|JCH_617_sm_Appendix-TableS1-S2.docx||17K||Supporting info item|
|JCH_617_sm_FigureS1.jpg||40K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.